3-Thiazoline, 2-ethyl-4-methyl-
Common Name: |
3-Thiazoline, 2-ethyl-4-methyl- |
IUPAC Name: |
2-ethyl-4-methyl-2,5-dihydro-1,3-thiazole |
Molecular Formula: |
C6H11NS |
SMILES: |
CCC1N=C(CS1)C |
Inchi: |
1S/C6H11NS/c1-3-6-7-5(2)4-8-6/h6H,3-4H2,1-2H3 |
Inchi Key: |
GKTIVNKILASSAW-UHFFFAOYSA-N |
Cas No: |
41803-21-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
129.22 |
Mass (g/mol) |
129.061 |
Molar Refractivity |
43.44 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
37.66 |
Hetero Atoms |
2 |
Heavy Atoms |
8 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
188.00 to 189.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.816 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.83 |
LogP |
1.93 |
iLOGP |
2.06 |
XLOGP3 |
1.43 |
WLOGP |
1.55 |
MLOGP |
1.00 |
ESOL Log S |
-1.48 |
ESOL Solubility (mg/ml) |
4.32 |
ESOL Solubility (mol/l) |
0.033 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.83 |
Ali Solubility (mg/ml) |
1.93 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.76 |
Silicos-IT Solubility (mg/ml) |
2.23 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.07 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.323 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.901 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |